دورية أكاديمية

Impaired Circulating CD4+LAP+ Regulatory T Cells in Patients with Acute Coronary Syndrome and Its Mechanistic Study.

التفاصيل البيبلوغرافية
العنوان: Impaired Circulating CD4+LAP+ Regulatory T Cells in Patients with Acute Coronary Syndrome and Its Mechanistic Study.
المؤلفون: Zhu, Zheng-Feng, Meng, Kai, Zhong, Yu-Cheng, Qi, Liang, Mao, Xiao-Bo, Yu, Kun-Wu, Zhang, Wei, Zhu, Peng-Fei, Ren, Ze-Peng, Wu, Bang-Wei, Ji, Qin-Wei, Wang, Xiang, Zeng, Qiu-Tang
المصدر: PLoS ONE; Feb2014, Vol. 9 Issue 2, p1-10, 10p
مصطلحات موضوعية: CD4 antigen, T cells, ACUTE coronary syndrome, CHEST pain, MEMBRANE proteins, GLYCOPROTEINS, MOLECULAR biology, PATIENTS
مستخلص: Objective: CD4+ latency-associated peptide (LAP)+ regulatory T cells (Tregs) are a newly discovered T cell subset in humans and the role of these cells in patients with acute coronary syndrome (ACS) has not been explored. We designed to investigate whether circulating frequency and function of CD4+LAP+ Tregs are defective in ACS. Methods: One hundred eleven ACS patients (acute myocardial infarction and unstable angina) and 117 control patients were enrolled in the study. The control patients consisted of chronic stable angina (CSA) and chest pain syndrome (CPS). The frequencies of circulating CD4+LAP+ Tregs and the expression of the transmembrane protein glycoprotein-A repetitions predominant (GARP) on CD4+ T cells were determined by flow cytometry. The function of CD4+LAP+ Tregs was detected using thymidine uptake. Serum interleukin-10 (IL-10) and transforming growth factor-β protein (TGF-β) levels were detected using ELISA and expression of GARP mRNA in peripheral blood mononuclear cells (PBMCs) was measured by real time-polymerase chain reaction. Results: We found ACS patients had a significantly lower frequency of circulating CD4+LAP+ Tregs, and the function of these cells was reduced compared to controls. The expression of GARP in CD4+ T cells and the serum levels of TGF-β in ACS patients were lower than those of control patients. The serum levels of IL-10 were similar between the two cohorts. Conclusions: A novel regulatory T cell subset, defined as CD4+LAP+ T cells is defective in ACS patients. [ABSTRACT FROM AUTHOR]
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19326203
DOI:10.1371/journal.pone.0088775